Camber Launches Indomethacin Suppositories

Camber Pharmaceuticals recently added Indomethacin Suppositories [IN-doe-METH-a-sin] to its portfolio.
Indomethacin Suppositories are a nonsteroidal anti-inflammatory drug indicated for:
- Moderate to severe rheumatoid arthritis including acute flares of chronic disease
- Moderate to severe ankylosing spondylitis
- Moderate to severe osteoarthritis
- Acute painful shoulder (bursitis and/or tendinitis)
- Acute gouty arthritis
Camber’s Indomethacin Suppositories are available in 50mg strength, supplied as 30 suppositories per package.
Click here to learn more about this product.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection